Sanofi is strategically developing its own AI ecosystem, aiming to enhance operational efficiency and maintain a competitive edge in the pharmaceutical sector.
Sanofi's chief digital officer, Emmanuel Frenehard, initially viewed existing AI tools, such as ChatGPT and Microsoft's Copilot, as inadequate for the company's needs. Instead of adopting these external solutions, Sanofi launched its own internal generative AI tool named Concierge, which has quickly gained traction among employees, serving about 80% of the workforce. This tool aggregates data from various sources, including internal policies and external vendor systems, enabling more streamlined operations.
Frenehard's vision extends beyond Concierge, focusing on leveraging agentic AI to transform workflows in IT, procurement, and sales. He aims for AI agents to autonomously handle a significant portion of employee requests, potentially saving millions annually. Additionally, Concierge is being rolled out to sales representatives, helping them prepare for meetings with healthcare professionals by providing relevant insights and data.
Sanofi's approach contrasts with the prevailing trend of relying on SaaS vendors for AI capabilities. By controlling its data and developing proprietary solutions, Sanofi seeks to create a unique software experience tailored to its specific needs. This could disrupt the traditional SaaS model, especially as the company partners with major AI players to enhance drug discovery processes.
This strategic pivot towards an in-house AI ecosystem underscores a growing recognition among CIOs of the importance of data control. As Sanofi continues to refine its AI capabilities, it positions itself to not only improve operational efficiency but also redefine its competitive landscape in the pharmaceutical industry.